Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study | AVESİS

Gazi University Research Information System

Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study

Copy For Citation

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., ...More

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30

Publication Type: Conference Paper / Summary Text
Volume: 30
City: Illinois
Country: United States Of America
Gazi University Affiliated: No